These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21250852)

  • 21. Biological monitoring of carcinogens: current status and perspectives.
    Pavanello S; Lotti M
    Arch Toxicol; 2012 Apr; 86(4):535-41. PubMed ID: 22159923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidance values for the biomonitoring of occupational exposure. State of the art.
    Aitio A
    Med Lav; 2006; 97(2):324-31. PubMed ID: 17017366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The increasing significance of biomonitoring for pesticides and organic pollutants.
    Tsatsakis AM; Christakis-Hampsas M; Liesivuori J
    Toxicol Lett; 2012 Apr; 210(2):107-9. PubMed ID: 22306370
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of response biomarkers in milk for assessing exposure to environmental contaminants: the case for dioxin-like compounds.
    Diehl-Jones WL; Bols NC
    J Toxicol Environ Health B Crit Rev; 2000; 3(2):79-107. PubMed ID: 10834077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant Escherichia coli for the biomonitoring of benzene and its derivatives in the air.
    Berno E; Pereira Marcondes DF; Ricci Gamalero S; Eandi M
    Ecotoxicol Environ Saf; 2004 Feb; 57(2):118-22. PubMed ID: 14759656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction, adaptation and recovery of biological responses: implications for environmental monitoring.
    Wu RS; Siu WH; Shin PK
    Mar Pollut Bull; 2005; 51(8-12):623-34. PubMed ID: 15893333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of benzene in the workplace and its evolution process, Part II: Present methods and future trends.
    Verma DK; des Tombe K
    Am Ind Hyg Assoc J; 1999; 60(1):48-56. PubMed ID: 10028616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cotinine--the biomarker of exposure to tobacco smoke].
    Dziuda MR; Grzybowski A
    Przegl Lek; 1999; 56(2):161-3. PubMed ID: 10375952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzene exposure in childhood: Role of living environments and assessment of available tools.
    Protano C; Guidotti M; Manini P; Petyx M; La Torre G; Vitali M
    Environ Int; 2010 Oct; 36(7):779-87. PubMed ID: 20591482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integration of human biomonitoring exposure data into risk assessment: HESI initiatives and perspectives.
    Doerrer NG
    Int J Hyg Environ Health; 2007 May; 210(3-4):247-51. PubMed ID: 17321214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring low benzene exposure: comparative evaluation of urinary biomarkers, influence of cigarette smoking, and genetic polymorphisms.
    Fustinoni S; Consonni D; Campo L; Buratti M; Colombi A; Pesatori AC; Bonzini M; Bertazzi PA; Foà V; Garte S; Farmer PB; Levy LS; Pala M; Valerio F; Fontana V; Desideri A; Merlo DF
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2237-44. PubMed ID: 16172237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of biomarkers in biomonitoring: a 2-tier approach assessing the level of pollutant-induced stress syndrome in sentinel organisms.
    Viarengo A; Lowe D; Bolognesi C; Fabbri E; Koehler A
    Comp Biochem Physiol C Toxicol Pharmacol; 2007 Sep; 146(3):281-300. PubMed ID: 17560835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Environmental chemicals in people: challenges in interpreting biomonitoring information.
    LaKind JS; Barraj L; Tran N; Aylward LL
    J Environ Health; 2008 May; 70(9):61-4. PubMed ID: 18517157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting the evaluation of biomonitoring data for human exposure assessment.
    Calafat AM; Needham LL
    Int J Androl; 2008 Apr; 31(2):139-43. PubMed ID: 17971164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective.
    Hays SM; Becker RA; Leung HW; Aylward LL; Pyatt DW
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):96-109. PubMed ID: 17030369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of biological samples for chemical warfare agents.
    Barr JR
    J Anal Toxicol; 2008; 32(1):1. PubMed ID: 18269785
    [No Abstract]   [Full Text] [Related]  

  • 38. Concentrations versus amounts of biomarkers in urine: a comparison of approaches to assess pyrethroid exposure.
    Fortin MC; Carrier G; Bouchard M
    Environ Health; 2008 Nov; 7():55. PubMed ID: 18983658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomonitoring of lead exposure-alternatives to blood.
    Bergdahl IA; Skerfving S
    J Toxicol Environ Health A; 2008; 71(18):1235-43. PubMed ID: 18654894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing measurements of biomarkers with other measurements of exposure.
    Saracci R
    IARC Sci Publ; 1997; (142):303-12. PubMed ID: 9354929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.